• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化阴离子交换色谱法测定重组激活凝血因子 VII 药物中 γ-羧基谷氨酸(Gla)结构域缺失杂质

Elimination of ghost peaks by optimization of anion exchange chromatography method for determination of gamma-carboxyglutamic acid (Gla)-domainless impurity in recombinant activated clotting factor VII drug products.

机构信息

Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran.

Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran.

出版信息

J Pharm Biomed Anal. 2019 Jul 15;171:1-7. doi: 10.1016/j.jpba.2019.03.011. Epub 2019 Mar 22.

DOI:10.1016/j.jpba.2019.03.011
PMID:30953797
Abstract

Secreted recombinant activated clotting factor VII activated (rFVIIa) in cell culture media missing gamma-carboxyglutamic acid (Gla) domain as a result of failure in gamma-carboxylation or cell lysis is called Gla-domainless impurity which has less negative charge compared to native rFVIIa. Based on risk assessment, this type of impurity is considered as critical drug product quality attribute of rFVIIa and its quantitative analysis in product batches is a critical issue in quality control laboratories. Analysis of Gla-domainless impurity is accomplished by Strong Anion Exchange Chromatography (SAX) in recombinant factor VIIa using Tris and Bis-Tris propane salt buffers as equilibrating buffers and high concentration ammonium acetate as an eluent. Appearance of ghost peaks with notable intensity during elution time of Gla-domainless impurity caused distortion of the related peak and interference with robust and accurate quantification of this impurity. Subsequently, the ghost peak was analyzed by LC-ESI-MS to determine the structure which showed the m/z values at 905.27, 623.53 and 341.60 and 563.73. To find the source of these ghost peaks, quality of water, buffer salts and Chelex-100 together with ionic strength of mobile phase A (addition of 25 mM NaCl) were considered as affecting parameters and several experiments designed with DOE software to optimize the best condition of highest quality the method with lowest signal of ghost peak noises. By interpretation of DOE result, it is concluded that high grade water and buffer salt along with high quality Chelex-100 resins are important factors to achieve a method with lowest ghost peaks. However, addition of 25 mM NaCl to mobile phase A with either lower quality buffer salts or lower water grade yields high quality chromatogram peak with acceptable ghost peaks. LC/MS analysis indicates that macrostructures of Bis-Tris propane made up as a result of hydrogen bonds with each other or Tris molecules can be the source of ghost peaks.

摘要

由于γ-羧化或细胞裂解失败而导致重组激活凝血因子 VII(rFVIIa)在细胞培养介质中缺失 γ-羧基谷氨酸(Gla)结构域的分泌型无 Gla 结构域杂质与天然 rFVIIa 相比,负电荷较少。基于风险评估,这种类型的杂质被认为是 rFVIIa 的关键药物产品质量属性,其在产品批次中的定量分析是质量控制实验室的关键问题。使用三羟甲基氨基甲烷和双三羟甲基丙烷盐缓冲液作为平衡缓冲液和高浓度乙酸铵作为洗脱液,通过强阴离子交换色谱(SAX)对无 Gla 结构域杂质进行分析。在无 Gla 结构域杂质的洗脱时间出现幽灵峰,其强度显著,导致相关峰变形,并对该杂质的稳健和准确定量造成干扰。随后,通过 LC-ESI-MS 对幽灵峰进行分析,以确定其结构,结果显示 m/z 值为 905.27、623.53、341.60 和 563.73。为了找到这些幽灵峰的来源,考虑了水的质量、缓冲盐和 Chelex-100 以及流动相 A 的离子强度(添加 25 mM NaCl)作为影响参数,并使用 DOE 软件设计了几个实验,以优化方法的最佳条件,即具有最低幽灵峰噪声的最高质量。通过 DOE 结果的解释,可以得出结论,高质量的水和缓冲盐以及高质量的 Chelex-100 树脂是实现最低幽灵峰方法的重要因素。然而,向流动相 A 中添加 25 mM NaCl,无论是使用质量较低的缓冲盐还是等级较低的水,都可以得到具有可接受幽灵峰的高质量色谱峰。LC/MS 分析表明,双三羟甲基丙烷的宏观结构可能是由于氢键与彼此或 Tris 分子相互作用而形成的,这可能是幽灵峰的来源。

相似文献

1
Elimination of ghost peaks by optimization of anion exchange chromatography method for determination of gamma-carboxyglutamic acid (Gla)-domainless impurity in recombinant activated clotting factor VII drug products.优化阴离子交换色谱法测定重组激活凝血因子 VII 药物中 γ-羧基谷氨酸(Gla)结构域缺失杂质
J Pharm Biomed Anal. 2019 Jul 15;171:1-7. doi: 10.1016/j.jpba.2019.03.011. Epub 2019 Mar 22.
2
Forced degradation and impurity profiling: recent trends in analytical perspectives.强制降解和杂质剖析:分析视角的最新趋势。
J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.
3
Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor.重组因子VIIa在大鼠骨骼中的蓄积:γ-羧基谷氨酸结构域的重要性以及与另一种维生素K依赖凝血因子IX的相关性
Pharmacol Toxicol. 1993 Sep;73(3):127-32. doi: 10.1111/j.1600-0773.1993.tb01549.x.
4
Monoclonal antibody (VII-M31) to bovine factor VII: a specific epitope in the gamma-carboxyglutamic acid domain.抗牛因子VII的单克隆抗体(VII-M31):γ-羧基谷氨酸结构域中的一个特异性表位。
J Biochem. 1990 Oct;108(4):654-62. doi: 10.1093/oxfordjournals.jbchem.a123258.
5
gamma-Carboxyglutamic acid (Gla)-domainless blood coagulation factor IXa species: preparation and properties.γ-羧基谷氨酸(Gla)无结构域的血液凝固因子IXa种类:制备与特性
J Biochem. 1991 Dec;110(6):990-6. doi: 10.1093/oxfordjournals.jbchem.a123701.
6
Stable adducts of nerve agents sarin, soman and cyclosarin with TRIS, TES and related buffer compounds--characterization by LC-ESI-MS/MS and NMR and implications for analytical chemistry.稳定的神经毒剂沙林、梭曼和环沙林与 TRIS、TES 和相关缓冲化合物的加合物 - 通过 LC-ESI-MS/MS 和 NMR 的表征及对分析化学的影响。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 15;878(17-18):1382-90. doi: 10.1016/j.jchromb.2010.01.043. Epub 2010 Feb 2.
7
Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid.
Biochem Biophys Res Commun. 1985 Jul 31;130(2):841-7. doi: 10.1016/0006-291x(85)90493-0.
8
High-performance liquid chromatography--mass spectrometry and electron-capture dissociation tandem mass spectrometry of osteocalcin. Determination of gamma-carboxyglutamic acid residues.骨钙素的高效液相色谱-质谱联用及电子捕获解离串联质谱分析。γ-羧基谷氨酸残基的测定。
J Chromatogr A. 2002 Jul 12;962(1-2):95-103. doi: 10.1016/s0021-9673(02)00451-x.
9
gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.γ-羧基谷氨酸36和40对人凝血因子IX的功能没有贡献。
Protein Sci. 1997 Jan;6(1):185-96. doi: 10.1002/pro.5560060121.
10
Synthesis and characterization of wild-type and variant gamma-carboxyglutamic acid-containing domains of factor VII.因子 VII 的野生型及含 γ-羧基谷氨酸结构域变体的合成与表征
Biochemistry. 1993 Dec 21;32(50):13949-55. doi: 10.1021/bi00213a026.